{"protocolSection": {"identificationModule": {"nctId": "NCT00530946", "orgStudyIdInfo": {"id": "A3841058"}, "organization": {"fullName": "Pfizer", "class": "INDUSTRY"}, "briefTitle": "A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin", "officialTitle": "A Multi-Center, Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin In The Treatment Of Concurrent Hypertension And Hyper-LDL-Cholesterolemia"}, "statusModule": {"statusVerifiedDate": "2021-01", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2007-09"}, "primaryCompletionDateStruct": {"date": "2008-04", "type": "ACTUAL"}, "completionDateStruct": {"date": "2008-04", "type": "ACTUAL"}, "studyFirstSubmitDate": "2007-09-13", "studyFirstSubmitQcDate": "2007-09-14", "studyFirstPostDateStruct": {"date": "2007-09-18", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2009-03-10", "resultsFirstSubmitQcDate": "2009-03-10", "resultsFirstPostDateStruct": {"date": "2009-04-13", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2021-01-26", "lastUpdatePostDateStruct": {"date": "2021-01-28", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "To assess the changes in the trough Systolic Blood Pressure (SBP) and the percent changes in Low Density Lipoprotein-Cholesterol (LDL-C) from baseline at Week 8 in the treatment period"}, "conditionsModule": {"conditions": ["Hypertension", "Hypercholesterolemia"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE3"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 165, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "CI-1038 2.5mg/5mg", "type": "ACTIVE_COMPARATOR", "interventionNames": ["Drug: Amlodipine 2.5mg/Atorvastatin 5mg"]}, {"label": "CI-1038 2.5mg/10mg", "type": "ACTIVE_COMPARATOR", "interventionNames": ["Drug: Amlodipine 2.5mg/Atorvastatin 10mg"]}, {"label": "CI-1038 5mg/5mg", "type": "ACTIVE_COMPARATOR", "interventionNames": ["Drug: Amlodipine 5mg/Atorvastatin 5mg"]}, {"label": "CI-1038 5mg/10mg", "type": "ACTIVE_COMPARATOR", "interventionNames": ["Drug: Amlodipine 5mg/Atorvastatin 10mg"]}], "interventions": [{"type": "DRUG", "name": "Amlodipine 2.5mg/Atorvastatin 5mg", "description": "Single pill combination, dosed once daily for 8 weeks", "armGroupLabels": ["CI-1038 2.5mg/5mg"]}, {"type": "DRUG", "name": "Amlodipine 2.5mg/Atorvastatin 10mg", "description": "Single pill combination, dosed once daily for 8 weeks", "armGroupLabels": ["CI-1038 2.5mg/10mg"]}, {"type": "DRUG", "name": "Amlodipine 5mg/Atorvastatin 5mg", "description": "Single pill combination, dosed once daily for 8 weeks", "armGroupLabels": ["CI-1038 5mg/5mg"]}, {"type": "DRUG", "name": "Amlodipine 5mg/Atorvastatin 10mg", "description": "Single pill combination, dosed once daily for 8 weeks", "armGroupLabels": ["CI-1038 5mg/10mg"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Change in Systolic Blood Pressure", "description": "Value at Week 8 minus value at baseline", "timeFrame": "8 weeks"}, {"measure": "Percent Change in Low Density Lipoprotein-Cholesterol", "description": "Percent of \"value at Week 8 minus value at baseline\" over value at baseline", "timeFrame": "8 weeks"}], "secondaryOutcomes": [{"measure": "Change in Systolic Blood Pressure From Baseline to Each Observation Point", "description": "Value at Week 2, Week 4, or Week 8 minus value at baseline", "timeFrame": "2 weeks, 4 weeks, and 8 weeks"}, {"measure": "Change in Diastolic Blood Pressure From Baseline to Each Observation Point", "description": "Value at Week 2, Week 4, or Week 8 minus value at baseline", "timeFrame": "2 weeks, 4 weeks , and 8 weeks"}, {"measure": "Percent Change in Low Density Lipoprotein-Cholesterol From Baseline to Each Observation Point", "description": "Percent of \"value at Week 2, Week 4, or Week 8 minus value at baseline\" over value at baseline", "timeFrame": "2 weeks, 4 weeks , and 8 weeks"}, {"measure": "Percent Change in Total Cholesterol From Baseline to Each Observation Point", "description": "Percent of \"value at Week 2, Week 4, or Week 8 minus value at baseline\" over value at baseline", "timeFrame": "2 weeks, 4 weeks , and 8 weeks"}, {"measure": "Percent Change in High Density Lipoprotein-Cholesterol From Baseline to Each Observation Point", "description": "Percent of \"value at Week 2, Week 4, or Week 8 minus value at baseline\" over value at baseline", "timeFrame": "2 weeks, 4 weeks , and 8 weeks"}, {"measure": "Percent Change in Triglycerides From Baseline to Each Observation Point", "description": "Percent of \"value at Week 2, Week 4, or Week 8 minus value at baseline\" over value at baseline", "timeFrame": "2 weeks, 4 weeks , and 8 weeks"}, {"measure": "Change in Low Density Lipoprotein-Cholesterol/ High Density Lipoprotein-Cholesterol Ratio (LDL-C/HDL-C) From Baseline to Each Observation Point", "description": "Value at Week 2, Week 4, or Week 8 minus value at baseline", "timeFrame": "2 weeks, 4 weeks, and 8 weeks"}, {"measure": "Change in Total Cholesterol/ High Density Lipoprotein-Cholesterol Ratio (TC/HDL-C) From Baseline to Each Observation Point", "description": "Value at Week 2, Week 4, or Week 8 minus value at baseline", "timeFrame": "2 weeks, 4 weeks , and 8 weeks"}, {"measure": "Change in Apolipoprotein B From Baseline to Each Observation Point", "description": "Value at Week 2, Week 4, or Week 8 minus value at baseline", "timeFrame": "2 weeks, 4 weeks, and 8 weeks"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* The out-patient with concurrent hypertension and hyper-LDL-cholesterolemia is a male or female \\>=20 to \\<80 years of age at Visit 1.\n* The SBP at Visit 4 (Week -1) and Visit 5 (Week 0) is continuously SBP \\>=140 mmHg and \\<180 mmHg,\n* LDL-C \\>=140 mg/dL and \\<250 mg/dL at Visit 3 (Week -2) and 4 (Week -1).\n\nExclusion Criteria:\n\n* Subjects who had experienced the following coronary artery disease within the past 3 months.\n* Myocardial infarction\n* Receiving PCI\uff08percutaneous coronary intervention\uff09or CABG (coronary artery bypass grafting)\n* Any clinically meaningful valvular disease\n* Subjects with a history of cerebrovascular diseases such as stroke or transient ischemic attack within the past 3 months.", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "20 Years", "maximumAge": "79 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Pfizer CT.gov Call Center", "affiliation": "Pfizer", "role": "STUDY_DIRECTOR"}], "locations": [{"facility": "Pfizer Investigational Site", "city": "Fukuoka-shi", "state": "Fukuoka-ken", "country": "Japan", "geoPoint": {"lat": 33.6, "lon": 130.41667}}, {"facility": "Pfizer Investigational Site", "city": "Kitakyushu-shi", "state": "Fukuoka-ken", "country": "Japan", "geoPoint": {"lat": 33.85181, "lon": 130.85034}}, {"facility": "Pfizer Investigational Site", "city": "Kurume-shi", "state": "Fukuoka-ken", "country": "Japan", "geoPoint": {"lat": 33.31667, "lon": 130.51667}}, {"facility": "Pfizer Investigational Site", "city": "Maebaru-shi", "state": "Fukuoka-ken", "country": "Japan"}, {"facility": "Pfizer Investigational Site", "city": "Annaka", "state": "Gunma", "country": "Japan", "geoPoint": {"lat": 36.33011, "lon": 138.89585}}, {"facility": "Pfizer Investigational Site", "city": "Sapporo-shi", "state": "Hokkaido", "country": "Japan", "geoPoint": {"lat": 43.06667, "lon": 141.35}}, {"facility": "Pfizer Investigational Site", "city": "Teine", "state": "Hokkaido", "country": "Japan"}, {"facility": "Pfizer Investigational Site", "city": "Yokohama-shi", "state": "Kanagawa-ken", "country": "Japan", "geoPoint": {"lat": 35.43333, "lon": 139.65}}, {"facility": "Pfizer Investigational Site", "city": "Yamashita-cho", "state": "Naka-ku, Kanagawa-ken", "country": "Japan"}, {"facility": "Pfizer Investigational Site", "city": "Kita-ku", "state": "Osaka-fu", "country": "Japan"}, {"facility": "Pfizer Investigational Site", "city": "Koshigaya-shi", "state": "Saitama-ken", "country": "Japan", "geoPoint": {"lat": 35.89035, "lon": 139.78916}}, {"facility": "Pfizer Investigational Site", "city": "Chofu", "state": "Tokyo", "country": "Japan", "geoPoint": {"lat": 35.64837, "lon": 139.55426}}, {"facility": "Pfizer Investigational Site", "city": "Kiyose", "state": "Tokyo", "country": "Japan"}, {"facility": "Pfizer Investigational Site", "city": "Setagaya-ku", "state": "Tokyo", "country": "Japan", "geoPoint": {"lat": 35.64825, "lon": 139.65376}}, {"facility": "Pfizer Investigational Site", "city": "Shinagawa-Ku", "state": "Tokyo", "country": "Japan", "geoPoint": {"lat": 33.63627, "lon": 133.00572}}, {"facility": "Pfizer Investigational Site", "city": "Shinagawa", "state": "Tokyo", "country": "Japan", "geoPoint": {"lat": 33.63627, "lon": 133.00572}}, {"facility": "Pfizer Investigational Site", "city": "Osaka", "country": "Japan", "geoPoint": {"lat": 34.69374, "lon": 135.50218}}]}, "referencesModule": {"seeAlsoLinks": [{"label": "To obtain contact information for a study center near you, click here.", "url": "https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A3841058&StudyName=A%20Randomized%20Study%20To%20Evaluate%20Efficacy%20And%20Safety%20Of%20A%20Fixed%20Combination%20Therapy%20Of%20Amlodipine%20And%20Atorvastatin"}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "A total of 301 subjects entered the 6-week diet observation period and the end of diet observation period, 165 subjects who met all the inclusion criteria for the treatment period and had no conflict to exclusion criteria were randomized to 4 CI-1038 groups.", "recruitmentDetails": "Twenty (20) centers in Japan", "groups": [{"id": "FG000", "title": "CI-1038 2.5 mg/5 mg", "description": "Amlodipine 2.5 mg/Atorvastatin 5 mg single pill combination (CI-1038 2.5mg/5mg)"}, {"id": "FG001", "title": "CI-1038 2.5 mg/10 mg", "description": "Amlodipine 2.5 mg/Atorvastatin 10 mg single pill combination (CI-1038 2.5 mg/10 mg)"}, {"id": "FG002", "title": "CI-1038 5 mg/5 mg", "description": "Amlodipine 5 mg/Atorvastatin 5 mg single pill combination (CI-1038 5 mg/5 mg)"}, {"id": "FG003", "title": "CI-1038 5 mg/10 mg", "description": "Amlodipine 5 mg/Atorvastatin 10 mg single pill combination (CI-1038 5 mg/10 mg)"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "43"}, {"groupId": "FG001", "numSubjects": "41"}, {"groupId": "FG002", "numSubjects": "41"}, {"groupId": "FG003", "numSubjects": "40"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "41"}, {"groupId": "FG001", "numSubjects": "39"}, {"groupId": "FG002", "numSubjects": "40"}, {"groupId": "FG003", "numSubjects": "38"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "2"}, {"groupId": "FG001", "numSubjects": "2"}, {"groupId": "FG002", "numSubjects": "1"}, {"groupId": "FG003", "numSubjects": "2"}]}], "dropWithdraws": [{"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "2"}, {"groupId": "FG002", "numSubjects": "1"}, {"groupId": "FG003", "numSubjects": "1"}]}, {"type": "Protocol Violation", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "1"}]}, {"type": "Noncompliance", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "CI-1038 2.5 mg/5 mg", "description": "Amlodipine 2.5 mg/Atorvastatin 5 mg single pill combination (CI-1038 2.5mg/5mg)"}, {"id": "BG001", "title": "CI-1038 2.5 mg/10 mg", "description": "Amlodipine 2.5 mg/Atorvastatin 10 mg single pill combination (CI-1038 2.5 mg/10 mg)"}, {"id": "BG002", "title": "CI-1038 5 mg/5 mg", "description": "Amlodipine 5 mg/Atorvastatin 5 mg single pill combination (CI-1038 5 mg/5 mg)"}, {"id": "BG003", "title": "CI-1038 5 mg/10 mg", "description": "Amlodipine 5 mg/Atorvastatin 10 mg single pill combination (CI-1038 5 mg/10 mg)"}, {"id": "BG004", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "43"}, {"groupId": "BG001", "value": "41"}, {"groupId": "BG002", "value": "41"}, {"groupId": "BG003", "value": "40"}, {"groupId": "BG004", "value": "165"}]}], "measures": [{"title": "Age, Customized", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "<20 years", "categories": [{"measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}]}]}, {"title": "20 to 44 years", "categories": [{"measurements": [{"groupId": "BG000", "value": "8"}, {"groupId": "BG001", "value": "3"}, {"groupId": "BG002", "value": "4"}, {"groupId": "BG003", "value": "5"}, {"groupId": "BG004", "value": "20"}]}]}, {"title": "45 to 64 years", "categories": [{"measurements": [{"groupId": "BG000", "value": "20"}, {"groupId": "BG001", "value": "21"}, {"groupId": "BG002", "value": "23"}, {"groupId": "BG003", "value": "23"}, {"groupId": "BG004", "value": "87"}]}]}, {"title": ">=65 years", "categories": [{"measurements": [{"groupId": "BG000", "value": "15"}, {"groupId": "BG001", "value": "17"}, {"groupId": "BG002", "value": "14"}, {"groupId": "BG003", "value": "12"}, {"groupId": "BG004", "value": "58"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "23"}, {"groupId": "BG001", "value": "28"}, {"groupId": "BG002", "value": "25"}, {"groupId": "BG003", "value": "22"}, {"groupId": "BG004", "value": "98"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "20"}, {"groupId": "BG001", "value": "13"}, {"groupId": "BG002", "value": "16"}, {"groupId": "BG003", "value": "18"}, {"groupId": "BG004", "value": "67"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "Japan", "categories": [{"measurements": [{"groupId": "BG000", "value": "43"}, {"groupId": "BG001", "value": "41"}, {"groupId": "BG002", "value": "41"}, {"groupId": "BG003", "value": "40"}, {"groupId": "BG004", "value": "165"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Change in Systolic Blood Pressure", "description": "Value at Week 8 minus value at baseline", "populationDescription": "Full Analysis Set, Last Observation Carried Forward", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "mm Hg", "timeFrame": "8 weeks", "groups": [{"id": "OG000", "title": "CI-1038 2.5 mg/5 mg", "description": "Amlodipine 2.5 mg/Atorvastatin 5 mg single pill combination (CI-1038 2.5mg/5mg)"}, {"id": "OG001", "title": "CI-1038 2.5 mg/10 mg", "description": "Amlodipine 2.5 mg/Atorvastatin 10 mg single pill combination (CI-1038 2.5 mg/10 mg)"}, {"id": "OG002", "title": "CI-1038 5 mg/5 mg", "description": "Amlodipine 5 mg/Atorvastatin 5 mg single pill combination (CI-1038 5 mg/5 mg)"}, {"id": "OG003", "title": "CI-1038 5 mg/10 mg", "description": "Amlodipine 5 mg/Atorvastatin 10 mg single pill combination (CI-1038 5 mg/10 mg)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "41"}, {"groupId": "OG002", "value": "41"}, {"groupId": "OG003", "value": "40"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-16.6", "spread": "1.65"}, {"groupId": "OG001", "value": "-15.9", "spread": "1.69"}, {"groupId": "OG002", "value": "-21.8", "spread": "1.69"}, {"groupId": "OG003", "value": "-18.9", "spread": "1.71"}]}]}]}, {"type": "PRIMARY", "title": "Percent Change in Low Density Lipoprotein-Cholesterol", "description": "Percent of \"value at Week 8 minus value at baseline\" over value at baseline", "populationDescription": "Full Analysis Set, Last Observation Carried Forward", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "Percent Change", "timeFrame": "8 weeks", "groups": [{"id": "OG000", "title": "CI-1038 2.5 mg/5 mg", "description": "Amlodipine 2.5 mg/Atorvastatin 5 mg single pill combination (CI-1038 2.5mg/5mg)"}, {"id": "OG001", "title": "CI-1038 2.5 mg/10 mg", "description": "Amlodipine 2.5 mg/Atorvastatin 10 mg single pill combination (CI-1038 2.5 mg/10 mg)"}, {"id": "OG002", "title": "CI-1038 5 mg/5 mg", "description": "Amlodipine 5 mg/Atorvastatin 5 mg single pill combination (CI-1038 5 mg/5 mg)"}, {"id": "OG003", "title": "CI-1038 5 mg/10 mg", "description": "Amlodipine 5 mg/Atorvastatin 10 mg single pill combination (CI-1038 5 mg/10 mg)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "41"}, {"groupId": "OG002", "value": "41"}, {"groupId": "OG003", "value": "40"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-37.2", "spread": "1.49"}, {"groupId": "OG001", "value": "-42.5", "spread": "1.52"}, {"groupId": "OG002", "value": "-34.3", "spread": "1.52"}, {"groupId": "OG003", "value": "-40.6", "spread": "1.54"}]}]}]}, {"type": "SECONDARY", "title": "Change in Systolic Blood Pressure From Baseline to Each Observation Point", "description": "Value at Week 2, Week 4, or Week 8 minus value at baseline", "populationDescription": "Full Analysis Set, Observed Cases", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mm Hg", "timeFrame": "2 weeks, 4 weeks, and 8 weeks", "groups": [{"id": "OG000", "title": "CI-1038 2.5 mg/5 mg", "description": "Amlodipine 2.5 mg/Atorvastatin 5 mg single pill combination (CI-1038 2.5mg/5mg)"}, {"id": "OG001", "title": "CI-1038 2.5 mg/10 mg", "description": "Amlodipine 2.5 mg/Atorvastatin 10 mg single pill combination (CI-1038 2.5 mg/10 mg)"}, {"id": "OG002", "title": "CI-1038 5 mg/5 mg", "description": "Amlodipine 5 mg/Atorvastatin 5 mg single pill combination (CI-1038 5 mg/5 mg)"}, {"id": "OG003", "title": "CI-1038 5 mg/10 mg", "description": "Amlodipine 5 mg/Atorvastatin 10 mg single pill combination (CI-1038 5 mg/10 mg)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "41"}, {"groupId": "OG002", "value": "41"}, {"groupId": "OG003", "value": "40"}]}], "classes": [{"title": "Week 2", "categories": [{"measurements": [{"groupId": "OG000", "value": "-12.8", "spread": "9.63"}, {"groupId": "OG001", "value": "-13.5", "spread": "10.18"}, {"groupId": "OG002", "value": "-19.2", "spread": "10.53"}, {"groupId": "OG003", "value": "-16.0", "spread": "9.01"}]}]}, {"title": "Week 4", "categories": [{"measurements": [{"groupId": "OG000", "value": "-14.2", "spread": "10.26"}, {"groupId": "OG001", "value": "-14.6", "spread": "12.33"}, {"groupId": "OG002", "value": "-20.2", "spread": "11.08"}, {"groupId": "OG003", "value": "-19.6", "spread": "11.03"}]}]}, {"title": "Week 8", "categories": [{"measurements": [{"groupId": "OG000", "value": "-16.8", "spread": "11.40"}, {"groupId": "OG001", "value": "-15.3", "spread": "11.59"}, {"groupId": "OG002", "value": "-21.3", "spread": "10.07"}, {"groupId": "OG003", "value": "-18.7", "spread": "11.24"}]}]}]}, {"type": "SECONDARY", "title": "Change in Diastolic Blood Pressure From Baseline to Each Observation Point", "description": "Value at Week 2, Week 4, or Week 8 minus value at baseline", "populationDescription": "Full Analysis Set, Observed Cases", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mm Hg", "timeFrame": "2 weeks, 4 weeks , and 8 weeks", "groups": [{"id": "OG000", "title": "CI-1038 2.5 mg/5 mg", "description": "Amlodipine 2.5 mg/Atorvastatin 5 mg single pill combination (CI-1038 2.5mg/5mg)"}, {"id": "OG001", "title": "CI-1038 2.5 mg/10 mg", "description": "Amlodipine 2.5 mg/Atorvastatin 10 mg single pill combination (CI-1038 2.5 mg/10 mg)"}, {"id": "OG002", "title": "CI-1038 5 mg/5 mg", "description": "Amlodipine 5 mg/Atorvastatin 5 mg single pill combination (CI-1038 5 mg/5 mg)"}, {"id": "OG003", "title": "CI-1038 5 mg/10 mg", "description": "Amlodipine 5 mg/Atorvastatin 10 mg single pill combination (CI-1038 5 mg/10 mg)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "41"}, {"groupId": "OG002", "value": "41"}, {"groupId": "OG003", "value": "40"}]}], "classes": [{"title": "Week 2", "categories": [{"measurements": [{"groupId": "OG000", "value": "-4.9", "spread": "6.23"}, {"groupId": "OG001", "value": "-6.0", "spread": "6.05"}, {"groupId": "OG002", "value": "-8.1", "spread": "6.24"}, {"groupId": "OG003", "value": "-8.2", "spread": "6.38"}]}]}, {"title": "Week 4", "categories": [{"measurements": [{"groupId": "OG000", "value": "-5.3", "spread": "4.96"}, {"groupId": "OG001", "value": "-8.2", "spread": "7.13"}, {"groupId": "OG002", "value": "-9.4", "spread": "6.19"}, {"groupId": "OG003", "value": "-9.2", "spread": "6.62"}]}]}, {"title": "Week 8", "categories": [{"measurements": [{"groupId": "OG000", "value": "-7.7", "spread": "6.34"}, {"groupId": "OG001", "value": "-8.7", "spread": "8.06"}, {"groupId": "OG002", "value": "-12.0", "spread": "6.31"}, {"groupId": "OG003", "value": "-9.9", "spread": "6.57"}]}]}]}, {"type": "SECONDARY", "title": "Percent Change in Low Density Lipoprotein-Cholesterol From Baseline to Each Observation Point", "description": "Percent of \"value at Week 2, Week 4, or Week 8 minus value at baseline\" over value at baseline", "populationDescription": "Full Analysis Set, Observed Cases", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Percent Change", "timeFrame": "2 weeks, 4 weeks , and 8 weeks", "groups": [{"id": "OG000", "title": "CI-1038 2.5 mg/5 mg", "description": "Amlodipine 2.5 mg/Atorvastatin 5 mg single pill combination (CI-1038 2.5mg/5mg)"}, {"id": "OG001", "title": "CI-1038 2.5 mg/10 mg", "description": "Amlodipine 2.5 mg/Atorvastatin 10 mg single pill combination (CI-1038 2.5 mg/10 mg)"}, {"id": "OG002", "title": "CI-1038 5 mg/5 mg", "description": "Amlodipine 5 mg/Atorvastatin 5 mg single pill combination (CI-1038 5 mg/5 mg)"}, {"id": "OG003", "title": "CI-1038 5 mg/10 mg", "description": "Amlodipine 5 mg/Atorvastatin 10 mg single pill combination (CI-1038 5 mg/10 mg)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "41"}, {"groupId": "OG002", "value": "41"}, {"groupId": "OG003", "value": "40"}]}], "classes": [{"title": "Week 2", "categories": [{"measurements": [{"groupId": "OG000", "value": "-34.8", "spread": "9.11"}, {"groupId": "OG001", "value": "-42.5", "spread": "11.00"}, {"groupId": "OG002", "value": "-32.8", "spread": "9.15"}, {"groupId": "OG003", "value": "-40.2", "spread": "13.52"}]}]}, {"title": "Week 4", "categories": [{"measurements": [{"groupId": "OG000", "value": "-37.4", "spread": "7.67"}, {"groupId": "OG001", "value": "-43.8", "spread": "9.30"}, {"groupId": "OG002", "value": "-35.0", "spread": "9.19"}, {"groupId": "OG003", "value": "-41.8", "spread": "9.53"}]}]}, {"title": "Week 8", "categories": [{"measurements": [{"groupId": "OG000", "value": "-37.6", "spread": "7.80"}, {"groupId": "OG001", "value": "-42.9", "spread": "10.28"}, {"groupId": "OG002", "value": "-34.2", "spread": "9.22"}, {"groupId": "OG003", "value": "-40.8", "spread": "11.28"}]}]}]}, {"type": "SECONDARY", "title": "Percent Change in Total Cholesterol From Baseline to Each Observation Point", "description": "Percent of \"value at Week 2, Week 4, or Week 8 minus value at baseline\" over value at baseline", "populationDescription": "Full Analysis Set, Observed Cases", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Percent Change", "timeFrame": "2 weeks, 4 weeks , and 8 weeks", "groups": [{"id": "OG000", "title": "CI-1038 2.5 mg/5 mg", "description": "Amlodipine 2.5 mg/Atorvastatin 5 mg single pill combination (CI-1038 2.5mg/5mg)"}, {"id": "OG001", "title": "CI-1038 2.5 mg/10 mg", "description": "Amlodipine 2.5 mg/Atorvastatin 10 mg single pill combination (CI-1038 2.5 mg/10 mg)"}, {"id": "OG002", "title": "CI-1038 5 mg/5 mg", "description": "Amlodipine 5 mg/Atorvastatin 5 mg single pill combination (CI-1038 5 mg/5 mg)"}, {"id": "OG003", "title": "CI-1038 5 mg/10 mg", "description": "Amlodipine 5 mg/Atorvastatin 10 mg single pill combination (CI-1038 5 mg/10 mg)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "41"}, {"groupId": "OG002", "value": "41"}, {"groupId": "OG003", "value": "40"}]}], "classes": [{"title": "Week 2", "categories": [{"measurements": [{"groupId": "OG000", "value": "-24.2", "spread": "6.86"}, {"groupId": "OG001", "value": "-30.5", "spread": "8.44"}, {"groupId": "OG002", "value": "-23.0", "spread": "7.22"}, {"groupId": "OG003", "value": "-28.3", "spread": "10.04"}]}]}, {"title": "Week 4", "categories": [{"measurements": [{"groupId": "OG000", "value": "-26.6", "spread": "6.36"}, {"groupId": "OG001", "value": "-31.5", "spread": "7.08"}, {"groupId": "OG002", "value": "-24.7", "spread": "7.64"}, {"groupId": "OG003", "value": "-28.6", "spread": "7.44"}]}]}, {"title": "Week 8", "categories": [{"measurements": [{"groupId": "OG000", "value": "-26.1", "spread": "6.01"}, {"groupId": "OG001", "value": "-30.0", "spread": "8.43"}, {"groupId": "OG002", "value": "-23.4", "spread": "7.78"}, {"groupId": "OG003", "value": "-28.2", "spread": "8.73"}]}]}]}, {"type": "SECONDARY", "title": "Percent Change in High Density Lipoprotein-Cholesterol From Baseline to Each Observation Point", "description": "Percent of \"value at Week 2, Week 4, or Week 8 minus value at baseline\" over value at baseline", "populationDescription": "Full Analysis Set, Observed Cases", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Percent Change", "timeFrame": "2 weeks, 4 weeks , and 8 weeks", "groups": [{"id": "OG000", "title": "CI-1038 2.5 mg/5 mg", "description": "Amlodipine 2.5 mg/Atorvastatin 5 mg single pill combination (CI-1038 2.5mg/5mg)"}, {"id": "OG001", "title": "CI-1038 2.5 mg/10 mg", "description": "Amlodipine 2.5 mg/Atorvastatin 10 mg single pill combination (CI-1038 2.5 mg/10 mg)"}, {"id": "OG002", "title": "CI-1038 5 mg/5 mg", "description": "Amlodipine 5 mg/Atorvastatin 5 mg single pill combination (CI-1038 5 mg/5 mg)"}, {"id": "OG003", "title": "CI-1038 5 mg/10 mg", "description": "Amlodipine 5 mg/Atorvastatin 10 mg single pill combination (CI-1038 5 mg/10 mg)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "41"}, {"groupId": "OG002", "value": "41"}, {"groupId": "OG003", "value": "40"}]}], "classes": [{"title": "Week 2", "categories": [{"measurements": [{"groupId": "OG000", "value": "7.7", "spread": "12.11"}, {"groupId": "OG001", "value": "8.3", "spread": "10.70"}, {"groupId": "OG002", "value": "6.6", "spread": "9.12"}, {"groupId": "OG003", "value": "9.9", "spread": "10.32"}]}]}, {"title": "Week 4", "categories": [{"measurements": [{"groupId": "OG000", "value": "7.2", "spread": "8.16"}, {"groupId": "OG001", "value": "7.9", "spread": "13.03"}, {"groupId": "OG002", "value": "9.3", "spread": "13.24"}, {"groupId": "OG003", "value": "11.9", "spread": "13.28"}]}]}, {"title": "Week 8", "categories": [{"measurements": [{"groupId": "OG000", "value": "7.2", "spread": "10.86"}, {"groupId": "OG001", "value": "7.5", "spread": "13.27"}, {"groupId": "OG002", "value": "9.7", "spread": "10.59"}, {"groupId": "OG003", "value": "10.8", "spread": "9.66"}]}]}]}, {"type": "SECONDARY", "title": "Percent Change in Triglycerides From Baseline to Each Observation Point", "description": "Percent of \"value at Week 2, Week 4, or Week 8 minus value at baseline\" over value at baseline", "populationDescription": "Full Analysis Set, Observed Cases", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Percent Change", "timeFrame": "2 weeks, 4 weeks , and 8 weeks", "groups": [{"id": "OG000", "title": "CI-1038 2.5 mg/5 mg", "description": "Amlodipine 2.5 mg/Atorvastatin 5 mg single pill combination (CI-1038 2.5mg/5mg)"}, {"id": "OG001", "title": "CI-1038 2.5 mg/10 mg", "description": "Amlodipine 2.5 mg/Atorvastatin 10 mg single pill combination (CI-1038 2.5 mg/10 mg)"}, {"id": "OG002", "title": "CI-1038 5 mg/5 mg", "description": "Amlodipine 5 mg/Atorvastatin 5 mg single pill combination (CI-1038 5 mg/5 mg)"}, {"id": "OG003", "title": "CI-1038 5 mg/10 mg", "description": "Amlodipine 5 mg/Atorvastatin 10 mg single pill combination (CI-1038 5 mg/10 mg)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "41"}, {"groupId": "OG002", "value": "41"}, {"groupId": "OG003", "value": "40"}]}], "classes": [{"title": "Week 2", "categories": [{"measurements": [{"groupId": "OG000", "value": "-15.1", "spread": "33.82"}, {"groupId": "OG001", "value": "-27.4", "spread": "22.48"}, {"groupId": "OG002", "value": "-16.2", "spread": "20.00"}, {"groupId": "OG003", "value": "-23.9", "spread": "24.51"}]}]}, {"title": "Week 4", "categories": [{"measurements": [{"groupId": "OG000", "value": "-14.2", "spread": "25.31"}, {"groupId": "OG001", "value": "-25.7", "spread": "18.15"}, {"groupId": "OG002", "value": "-15.1", "spread": "22.42"}, {"groupId": "OG003", "value": "-23.2", "spread": "28.55"}]}]}, {"title": "Week 8", "categories": [{"measurements": [{"groupId": "OG000", "value": "-14.1", "spread": "19.72"}, {"groupId": "OG001", "value": "-21.1", "spread": "21.68"}, {"groupId": "OG002", "value": "-10.8", "spread": "31.42"}, {"groupId": "OG003", "value": "-24.0", "spread": "25.15"}]}]}]}, {"type": "SECONDARY", "title": "Change in Low Density Lipoprotein-Cholesterol/ High Density Lipoprotein-Cholesterol Ratio (LDL-C/HDL-C) From Baseline to Each Observation Point", "description": "Value at Week 2, Week 4, or Week 8 minus value at baseline", "populationDescription": "Full Analysis Set, Observed Cases", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Ratio", "timeFrame": "2 weeks, 4 weeks, and 8 weeks", "groups": [{"id": "OG000", "title": "CI-1038 2.5 mg/5 mg", "description": "Amlodipine 2.5 mg/Atorvastatin 5 mg single pill combination (CI-1038 2.5mg/5mg)"}, {"id": "OG001", "title": "CI-1038 2.5 mg/10 mg", "description": "Amlodipine 2.5 mg/Atorvastatin 10 mg single pill combination (CI-1038 2.5 mg/10 mg)"}, {"id": "OG002", "title": "CI-1038 5 mg/5 mg", "description": "Amlodipine 5 mg/Atorvastatin 5 mg single pill combination (CI-1038 5 mg/5 mg)"}, {"id": "OG003", "title": "CI-1038 5 mg/10 mg", "description": "Amlodipine 5 mg/Atorvastatin 10 mg single pill combination (CI-1038 5 mg/10 mg)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "41"}, {"groupId": "OG002", "value": "41"}, {"groupId": "OG003", "value": "40"}]}], "classes": [{"title": "Week 2", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.2", "spread": "0.58"}, {"groupId": "OG001", "value": "-1.4", "spread": "0.42"}, {"groupId": "OG002", "value": "-1.1", "spread": "0.49"}, {"groupId": "OG003", "value": "-1.3", "spread": "0.53"}]}]}, {"title": "Week 4", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.3", "spread": "0.41"}, {"groupId": "OG001", "value": "-1.4", "spread": "0.42"}, {"groupId": "OG002", "value": "-1.2", "spread": "0.56"}, {"groupId": "OG003", "value": "-1.4", "spread": "0.49"}]}]}, {"title": "Week 8", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.2", "spread": "0.37"}, {"groupId": "OG001", "value": "-1.4", "spread": "0.44"}, {"groupId": "OG002", "value": "-1.2", "spread": "0.52"}, {"groupId": "OG003", "value": "-1.4", "spread": "0.52"}]}]}]}, {"type": "SECONDARY", "title": "Change in Total Cholesterol/ High Density Lipoprotein-Cholesterol Ratio (TC/HDL-C) From Baseline to Each Observation Point", "description": "Value at Week 2, Week 4, or Week 8 minus value at baseline", "populationDescription": "Full Analysis Set, Observed Cases", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Ratio", "timeFrame": "2 weeks, 4 weeks , and 8 weeks", "groups": [{"id": "OG000", "title": "CI-1038 2.5 mg/5 mg", "description": "Amlodipine 2.5 mg/Atorvastatin 5 mg single pill combination (CI-1038 2.5mg/5mg)"}, {"id": "OG001", "title": "CI-1038 2.5 mg/10 mg", "description": "Amlodipine 2.5 mg/Atorvastatin 10 mg single pill combination (CI-1038 2.5 mg/10 mg)"}, {"id": "OG002", "title": "CI-1038 5 mg/5 mg", "description": "Amlodipine 5 mg/Atorvastatin 5 mg single pill combination (CI-1038 5 mg/5 mg)"}, {"id": "OG003", "title": "CI-1038 5 mg/10 mg", "description": "Amlodipine 5 mg/Atorvastatin 10 mg single pill combination (CI-1038 5 mg/10 mg)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "41"}, {"groupId": "OG002", "value": "41"}, {"groupId": "OG003", "value": "40"}]}], "classes": [{"title": "Week 2", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.3", "spread": "0.71"}, {"groupId": "OG001", "value": "-1.6", "spread": "0.49"}, {"groupId": "OG002", "value": "-1.2", "spread": "0.61"}, {"groupId": "OG003", "value": "-1.5", "spread": "0.64"}]}]}, {"title": "Week 4", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.4", "spread": "0.48"}, {"groupId": "OG001", "value": "-1.6", "spread": "0.49"}, {"groupId": "OG002", "value": "-1.4", "spread": "0.69"}, {"groupId": "OG003", "value": "-1.6", "spread": "0.59"}]}]}, {"title": "Week 8", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.3", "spread": "0.43"}, {"groupId": "OG001", "value": "-1.5", "spread": "0.51"}, {"groupId": "OG002", "value": "-1.4", "spread": "0.65"}, {"groupId": "OG003", "value": "-1.5", "spread": "0.62"}]}]}]}, {"type": "SECONDARY", "title": "Change in Apolipoprotein B From Baseline to Each Observation Point", "description": "Value at Week 2, Week 4, or Week 8 minus value at baseline", "populationDescription": "Full Analysis Set, Observed Cases", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg/dL", "timeFrame": "2 weeks, 4 weeks, and 8 weeks", "groups": [{"id": "OG000", "title": "CI-1038 2.5 mg/5 mg", "description": "Amlodipine 2.5 mg/Atorvastatin 5 mg single pill combination (CI-1038 2.5mg/5mg)"}, {"id": "OG001", "title": "CI-1038 2.5 mg/10 mg", "description": "Amlodipine 2.5 mg/Atorvastatin 10 mg single pill combination (CI-1038 2.5 mg/10 mg)"}, {"id": "OG002", "title": "CI-1038 5 mg/5 mg", "description": "Amlodipine 5 mg/Atorvastatin 5 mg single pill combination (CI-1038 5 mg/5 mg)"}, {"id": "OG003", "title": "CI-1038 5 mg/10 mg", "description": "Amlodipine 5 mg/Atorvastatin 10 mg single pill combination (CI-1038 5 mg/10 mg)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "41"}, {"groupId": "OG002", "value": "41"}, {"groupId": "OG003", "value": "40"}]}], "classes": [{"title": "Week 2", "categories": [{"measurements": [{"groupId": "OG000", "value": "-36.6", "spread": "12.55"}, {"groupId": "OG001", "value": "-45.8", "spread": "12.11"}, {"groupId": "OG002", "value": "-33.5", "spread": "9.86"}, {"groupId": "OG003", "value": "-44.4", "spread": "15.46"}]}]}, {"title": "Week 4", "categories": [{"measurements": [{"groupId": "OG000", "value": "-40.1", "spread": "10.94"}, {"groupId": "OG001", "value": "-47.2", "spread": "10.20"}, {"groupId": "OG002", "value": "-36.6", "spread": "11.36"}, {"groupId": "OG003", "value": "-45.8", "spread": "13.79"}]}]}, {"title": "Week 8", "categories": [{"measurements": [{"groupId": "OG000", "value": "-40.2", "spread": "9.65"}, {"groupId": "OG001", "value": "-46.4", "spread": "10.87"}, {"groupId": "OG002", "value": "-36.6", "spread": "12.27"}, {"groupId": "OG003", "value": "-45.1", "spread": "14.39"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "3", "eventGroups": [{"id": "EG000", "title": "CI-1038 2.5 mg/5 mg", "description": "Amlodipine 2.5 mg/Atorvastatin 5 mg single pill combination (CI-1038 2.5mg/5mg)", "seriousNumAffected": 0, "seriousNumAtRisk": 43, "otherNumAffected": 6, "otherNumAtRisk": 43}, {"id": "EG001", "title": "CI-1038 2.5 mg/10 mg", "description": "Amlodipine 2.5 mg/Atorvastatin 10 mg single pill combination (CI-1038 2.5 mg/10 mg)", "seriousNumAffected": 0, "seriousNumAtRisk": 41, "otherNumAffected": 7, "otherNumAtRisk": 41}, {"id": "EG002", "title": "CI-1038 5 mg/5 mg", "description": "Amlodipine 5 mg/Atorvastatin 5 mg single pill combination (CI-1038 5 mg/5 mg)", "seriousNumAffected": 0, "seriousNumAtRisk": 41, "otherNumAffected": 8, "otherNumAtRisk": 41}, {"id": "EG003", "title": "CI-1038 5 mg/10 mg", "description": "Amlodipine 5 mg/Atorvastatin 10 mg single pill combination (CI-1038 5 mg/10 mg)", "seriousNumAffected": 0, "seriousNumAtRisk": 40, "otherNumAffected": 8, "otherNumAtRisk": 40}], "otherEvents": [{"term": "Nausea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 11.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 43}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 41}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 41}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 40}]}, {"term": "Seasonal Allergy", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA 11.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 43}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 41}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 41}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 40}]}, {"term": "Nasopharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 11.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 6, "numAtRisk": 43}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 41}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 41}, {"groupId": "EG003", "numAffected": 7, "numAtRisk": 40}]}, {"term": "Pain in Extremity", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 11.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 43}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 41}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 41}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 40}]}, {"term": "Headache", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 11.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 43}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 41}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 41}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 40}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "Pfizer has the right to review disclosures, requesting a delay of \\< 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), \\< 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results."}, "pointOfContact": {"title": "Pfizer ClinicalTrials.gov Call Center", "organization": "Pfizer, Inc.", "email": "ClinicalTrials.govCallCenter@pfizer.com", "phone": "1-800-718-1021"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-07-01"}, "conditionBrowseModule": {"meshes": [{"id": "D000006973", "term": "Hypertension"}, {"id": "D000006937", "term": "Hypercholesterolemia"}], "ancestors": [{"id": "D000014652", "term": "Vascular Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}, {"id": "D000006949", "term": "Hyperlipidemias"}, {"id": "D000050171", "term": "Dyslipidemias"}, {"id": "D000052439", "term": "Lipid Metabolism Disorders"}, {"id": "D000008659", "term": "Metabolic Diseases"}], "browseLeaves": [{"id": "M10024", "name": "Hypertension", "asFound": "Hypertension", "relevance": "HIGH"}, {"id": "M9988", "name": "Hypercholesterolemia", "asFound": "Hypercholesterolemia", "relevance": "HIGH"}, {"id": "M17400", "name": "Vascular Diseases", "relevance": "LOW"}, {"id": "M10000", "name": "Hyperlipidemias", "relevance": "LOW"}, {"id": "M10002", "name": "Hyperlipoproteinemias", "relevance": "LOW"}, {"id": "M26181", "name": "Dyslipidemias", "relevance": "LOW"}, {"id": "M11639", "name": "Metabolic Diseases", "relevance": "LOW"}, {"id": "M27029", "name": "Lipid Metabolism Disorders", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC18", "name": "Nutritional and Metabolic Diseases"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000017311", "term": "Amlodipine"}, {"id": "D000069059", "term": "Atorvastatin"}], "ancestors": [{"id": "D000000924", "term": "Anticholesteremic Agents"}, {"id": "D000000960", "term": "Hypolipidemic Agents"}, {"id": "D000000963", "term": "Antimetabolites"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}, {"id": "D000057847", "term": "Lipid Regulating Agents"}, {"id": "D000019161", "term": "Hydroxymethylglutaryl-CoA Reductase Inhibitors"}, {"id": "D000004791", "term": "Enzyme Inhibitors"}, {"id": "D000000959", "term": "Antihypertensive Agents"}, {"id": "D000002121", "term": "Calcium Channel Blockers"}, {"id": "D000049990", "term": "Membrane Transport Modulators"}, {"id": "D000077264", "term": "Calcium-Regulating Hormones and Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000014665", "term": "Vasodilator Agents"}], "browseLeaves": [{"id": "M351", "name": "Atorvastatin", "asFound": "General", "relevance": "HIGH"}, {"id": "M19600", "name": "Amlodipine", "asFound": "Healthy Volunteers", "relevance": "HIGH"}, {"id": "M223699", "name": "Amlodipine, atorvastatin drug combination", "relevance": "LOW"}, {"id": "M4243", "name": "Anticholesteremic Agents", "relevance": "LOW"}, {"id": "M4278", "name": "Hypolipidemic Agents", "relevance": "LOW"}, {"id": "M4281", "name": "Antimetabolites", "relevance": "LOW"}, {"id": "M28883", "name": "Lipid Regulating Agents", "relevance": "LOW"}, {"id": "M21155", "name": "Hydroxymethylglutaryl-CoA Reductase Inhibitors", "relevance": "LOW"}, {"id": "M7951", "name": "Enzyme Inhibitors", "relevance": "LOW"}, {"id": "M4277", "name": "Antihypertensive Agents", "relevance": "LOW"}, {"id": "M5381", "name": "Calcium", "relevance": "LOW"}, {"id": "M5398", "name": "Calcium, Dietary", "relevance": "LOW"}, {"id": "M5384", "name": "Calcium Channel Blockers", "relevance": "LOW"}, {"id": "M9789", "name": "Hormones", "relevance": "LOW"}, {"id": "M17412", "name": "Vasodilator Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Lipd", "name": "Lipid Regulating Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "AnAg", "name": "Antihypertensive Agents"}, {"abbrev": "ChanBlk", "name": "Channel Blockers"}, {"abbrev": "VaDiAg", "name": "Vasodilator Agents"}, {"abbrev": "BDCA", "name": "Bone Density Conservation Agents"}]}}, "hasResults": true}